Drug Name:Strontium Ranelate
Drug Class:Bone Density Regulator
Mechanism of Action:
  • Increases bone formation by osteoblasts
  • Decreases bone resorption by osteoclasts
Use:
  • Treatment of osteoporosis in postmenopausal women and men at high risk of fracture
  • Reduces the risk of vertebral and hip fractures
Side Effects:
  • Nausea
  • Diarrhea
  • Headache
  • Dizziness
  • Skin rash
  • Increased risk of blood clots
Contraindications:
  • Hypersensitivity to strontium ranelate
  • Severe renal impairment
  • Pregnancy and breastfeeding
Specialty:
  • Rheumatology
  • Endocrinology
  • Geriatrics